← All sarcoma trials
Recruiting now—Ages 18 Years and up

Real-World Study of DLBCL With Different Genetic Subtypes

Sponsor: Ruijin Hospital · NCT06026488 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

DLBCL - Diffuse Large B Cell LymphomaLymphoma

What it tests

  • Otherother

Where it's running1 site

1 international site

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China 200025

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Histologically-confirmed diffuse large B-cell lymphoma (DLBCL)
* Genetic subtype belonging to at least one of the seven subtypes by using next generation sequencing: MCD, BN2, N1, ST2, A53, EZB (MYC+, MYC-) and others
* Fully comprehension and signature of the informed consent form (ICF) for participation

Exclusion Criteria:

* Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period
* Severe mental illness
* Patients deemed unsuitable for inclusion by the investigator

Updated 2024-12-19 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.